文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛儿科与产科急症

COVID-19与季节性流感住院患者特征、发病率及死亡率的比较:一项全国性、基于人群的回顾性队列研究

Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study.
PubMed 文献 · Lancet Respir Med · 2020-12-17

COVID-19患者更常肥胖、超重、糖尿病、高血压和血脂异常,更常发生急性呼吸衰竭、肺栓塞、脓毒性休克或出血性卒中,但心肌梗死或房颤较少。

要点

  • COVID-19患者较流感更常发生急性呼吸衰竭、肺栓塞、脓毒性休克或出血性卒中,但心肌梗死或房颤较少。
  • COVID-19患者更常肥胖或超重、糖尿病、高血压、血脂异常;流感患者更常心衰、慢性呼吸疾病、肝硬化、缺铁性贫血。

适用人群与场景

  • 2020年3月1日至4月30日法国所有因COVID-19住院的患者(ICD-10编码U07.10、U07.11、U07.12、U07.14或U07.15)及2018年12月1日至2019年2月28日因流感住院的患者(ICD-10编码J09、J10或J11)。
  • 诊断编码包括主要、相关或关联诊断。
  • 数据按年龄组分层分析。

诊断标准与关键阈值

  • COVID-19诊断依据ICD-10编码U07.10、U07.11、U07.12、U07.14或U07.15。
  • 流感诊断依据ICD-10编码J09、J10或J11。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • COVID-19住院患者更常发生急性呼吸衰竭、肺栓塞、脓毒性休克或出血性卒中,需警惕这些并发症。

研究设计与关键结果

  • COVID-19患者中位年龄68岁(IQR 52-82),流感71岁(IQR 34-84)。
  • COVID-19患者更常发生急性呼吸衰竭、肺栓塞、脓毒性休克或出血性卒中,较少发生心肌梗死或房颤。

证据类型、等级与局限

  • 研究类型:全国性、基于人群的回顾性队列研究。
  • 局限:回顾性设计,依赖行政编码,可能存在编码偏倚;儿童亚组样本量小,作者指出低患者数量限制结论。

对床旁实践的改变

  • 提示COVID-19住院患者较流感有更高的死亡风险和呼吸系统并发症,应加强预防措施。
  • 强调需要特异性疫苗和治疗。
  • 儿童COVID-19住院率虽低,但<5岁需重症监护比例更高,青少年死亡率更高,需关注。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: To date, influenza epidemics have been considered suitable for use as a model for the COVID-19 epidemic, given that they are respiratory diseases with similar modes of transmission. However, data directly comparing the two diseases are scarce.

METHODS: We did a nationwide retrospective cohort study using the French national administrative database (PMSI), which includes discharge summaries for all hospital admissions in France. All patients hospitalised for COVID-19 from March 1 to April 30, 2020, and all patients hospitalised for influenza between Dec 1, 2018, and Feb 28, 2019, were included. The diagnosis of COVID-19 (International Classification of Diseases [10th edition] codes U07.10, U07.11, U07.12, U07.14, or U07.15) or influenza (J09, J10, or J11) comprised primary, related, or associated diagnosis. Comparisons of risk factors, clinical characteristics, and outcomes between patients hospitalised for COVID-19 and influenza were done, with data also stratified by age group.

FINDINGS: 89 530 patients with COVID-19 and 45 819 patients with influenza were hospitalised in France during the respective study periods. The median age of patients was 68 years (IQR 52-82) for COVID-19 and 71 years (34-84) for influenza. Patients with COVID-19 were more frequently obese or overweight, and more frequently had diabetes, hypertension, and dyslipidaemia than patients with influenza, whereas those with influenza more frequently had heart failure, chronic respiratory disease, cirrhosis, and deficiency anaemia. Patients admitted to hospital with COVID-19 more frequently developed acute respiratory failure, pulmonary embolism, septic shock, or haemorrhagic stroke than patients with influenza, but less frequently developed myocardial infarction or atrial fibrillation. In-hospital mortality was higher in patients with COVID-19 than in patients with influenza (15 104 [16·9%] of 89 530 vs 2640 [5·8%] of 45 819), with a relative risk of death of 2·9 (95% CI 2·8-3·0) and an age-standardised mortality ratio of 2·82. Of the patients hospitalised, the proportion of paediatric patients (<18 years) was smaller for COVID-19 than for influenza (1227 [1·4%] vs 8942 [19·5%]), but a larger proportion of patients younger than 5 years needed intensive care support for COVID-19 than for influenza (14 [2·3%] of 613 vs 65 [0·9%] of 6973). In adolescents (11-17 years), the in-hospital mortality was ten-times higher for COVID-19 than for influenza (five [1·1% of 458 vs one [0·1%] of 804), and patients with COVID-19 were more frequently obese or overweight.

INTERPRETATION: The presentation of patients with COVID-19 and seasonal influenza requiring hospitalisation differs considerably. Severe acute respiratory syndrome coronavirus 2 is likely to have a higher potential for respiratory pathogenicity, leading to more respiratory complications and to higher mortality. In children, although the rate of hospitalisation for COVID-19 appears to be lower than for influenza, in-hospital mortality is higher; however, low patient numbers limit this finding. These findings highlight the importance of appropriate preventive measures for COVID-19, as well as the need for a specific vaccine and treatment.

FUNDING: French National Research Agency.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

参考来源

  1. Piroth L, Cottenet J, Mariet AS, et al. Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study. Lancet Respir Med. 2020. PMID: 33341155. doi:10.1016/S2213-2600(20)30527-0

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。